No drugs for prions: could new approaches alleviate therapeutic scarcity?
The development of therapeutics for transmissible spongiform encephalopathies (TSEs) continues to be challenged by the complex nature of these diseases. Also referred to as prion diseases, TSEs are rare and...
Comment
View MoreThe new safety mandate driving AI-ready pharmacovigilance
Regulatory expectations in the drug safety industry have evolved faster in the past five years than in the previous two decades combined. The US Food and Drug Administration (FDA), the…
When trillion‑member libraries meet physics: what diversity really means
The hidden crisis in regenerative medicine
FDA inspection reveals critical supply chain vulnerabilities
Real-time data: how to gain an edge amid clinical services consolidation